Page 51 - ARNM-2-4
P. 51

Advances in Radiotherapy
            & Nuclear Medicine                                             Outcomes of durations in 2D and 3D BT for CCA



            Consent for publication                               Radiat Oncol Biol Phys. 1995;32(5):1301-1307.

            The patients gave consent to publish their data.      doi: 10.1016/0360-3016(94)00635-X
                                                               10.  Lanciano RM, Martz K, Coia LR, Hanks GE. Tumor and
            Availability of data                                  treatment factors improving outcome in stage III-B cervix

            Data is available from the corresponding author upon   cancer. Int J Radiat Oncol Biol Phys. 1991;20(1):95-100.
            reasonable request.                                   doi: 10.1016/0360-3016(91)90143-r

            References                                         11.  Karlsson J, Dreifaldt AC, Mordhorst LB, Sorbe B. Differences
                                                                  in outcome for cervical cancer patients treated with or
            1.   Han K, Milosevic M, Fyles A, Pintilie M, Viswanathan  AN.   without brachytherapy. Brachytherapy. 2017;16(1):133-140.
               Trends in the utilization of brachytherapy in cervical      doi: 10.1016/j.brachy.2016.09.011
               cancer  in  the  United  States.  Int J Radiat Oncol Biol Phys.
               2013;87(1):111-119.                             12.  Campitelli M, Lazzari R, Piccolo F, et al. Brachytherapy or
                                                                  external beam radiotherapy as a boost in locally advanced
               doi: 10.1016/j.ijrobp.2013.05.033
                                                                  cervical cancer: A Gynaecology Study Group in the Italian
            2.   Gill BS, Lin JF, Krivak TC, et al. National Cancer Data Base   Association of Radiation and Clinical Oncology (AIRO)
               analysis of radiation therapy consolidation modality for cervical   review. Int J Gynecol Cancer. 2021;31(9):1278-1286.
               cancer: The impact of new technological advancements. Int J      doi: 10.1136/ijgc-2020-002310
               Radiat Oncol Biol Phys. 2014;90(5):1083-1090.
                                                               13.  Chargari C, Renard S, Espenel S, et al. Can stereotactic body
               doi: 10.1016/j.ijrobp.2014.07.017
                                                                  radiotherapy replace brachytherapy for locally advanced
            3.   Chino J, Annunziata CM, Beriwal S, et al. Radiation therapy   cervical cancer? French society for radiation oncology
               for cervical cancer: Executive summary of an ASTRO clinical   statement. Cancer Radiother. 2020;24(6-7):706-713.
               practice guideline. Pract Radiat Oncol. 020;10(4):220-234.
                                                                  doi: 10.1016/j.canrad.2020.05.003
               doi: 10.1016/j.prro.2020.04.002
                                                               14.  Holschneider CH, Petereit DG, Chu C, et al. Brachytherapy:
            4.  Tornero-López  AM,  Guirado  D.  Radiobiological  A  critical component of primary radiation therapy for
               considerations in combining doses from external beam   cervical cancer: From the Society of Gynecologic Oncology
               radiotherapy and  brachytherapy  for  cervical  cancer.  Rep   (SGO) and the American Brachytherapy Society (ABS).
               Pract Oncol Radiother. 2018;23(6):562-573.         Gynecol Oncol. 2019;152(3):540-547.
               doi: 10.1016/j.rpor.2018.05.007                    doi: 10.1016/j.ygyno.2018.10.016
            5.   Viswanathan AN, Beriwal S, De Los Santos JF,  et al.   15.  Fields EC, Hazell S, Morcos M, Schmidt EJ, Chargari C,
               American Brachytherapy Society consensus guidelines for   Viswanathan AN. Image-guided gynecologic brachytherapy
               locally advanced carcinoma of the cervix. Part  II: High-  for cervical cancer. Semin Radiat Oncol. 2020;30(1):16-28.
               dose-rate brachytherapy. Brachytherapy. 2012;11(1):47-52.
                                                                  doi: 10.1016/j.semradonc.2019.08.010
               doi: 10.1016/j.brachy.2011.07.002
                                                               16.  Tan LT, Tanderup K, Kirisits C, et al. Image-guided adaptive
            6.   Song S, Rudra S, Hasselle MD, et al. The effect of treatment time   radiotherapy in cervical cancer.  Semin Radiat Oncol.
               in locally advanced cervical cancer in the era of concurrent   2019;29(3):284-298.
               chemoradiotherapy. Cancer. 2013;119(2):325-331.
                                                                  doi: 10.1016/j.semradonc.2019.02.010
               doi: 10.1002/cncr.27652
                                                               17.  Faye MD, Petruccelli Araujo M, Wissing MD, et al. Safety
            7.   Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment   and efficacy of 2D brachytherapy vs. 3D image-guided
               duration in the local control of cervix cancer.  Radiother   adaptive brachytherapy for locally advanced cervical
               Oncol. 1992;25(4):273-279.                         cancer-a single institution retrospective study. Curr Oncol.
                                                                  2023;30(5):4966-4978.
               doi: 10.1016/0167-8140(92)90247-r
                                                                  doi: 10.3390/curroncol30050375
            8.   Perez CA, Grigsby PW, Castro-Vita H, Lockett MA.
               Carcinoma of the uterine cervix. I. Impact of prolongation   18.  Sturdza A, Potter R, Fokdal LU,  et al. Image guided
               of overall treatment time and timing of brachytherapy on   brachytherapy in locally advanced cervical cancer: Improved
               outcome of radiation therapy. Int J Radiat Oncol Biol Phys.   pelvic control and survival in RetroEMBRACE, a multicenter
               1995;32(5):1275-1288.                              cohort study. Radiother Oncol. 2016;120(3):428-433.
               doi: 10.1016/0360-3016(95)00220-S                  doi: 10.1016/j.radonc.2016.03.011
            9.   Petereit DG, Sarkaria JN, Chappell R,  et al. The adverse   19.  Lin AJ, Kidd E, Dehdashti F,  et al. Intensity modulated
               effect of treatment prolongation in cervical carcinoma. Int J   radiation therapy and image-guided adapted brachytherapy


            Volume 2 Issue 4 (2024)                         11                             doi: 10.36922/arnm.4310
   46   47   48   49   50   51   52   53   54   55   56